Followers | 46 |
Posts | 3734 |
Boards Moderated | 0 |
Alias Born | 09/18/2018 |
Friday, December 31, 2021 1:47:03 PM
that would be James A. Ballas.
I think GPL exiting the UBQU short play as a toxic converter was a very important and good step.
indeed there is much work to be done before a squeeze can happen, but Ballas hired a new IR person, Ms. Preya, and she's a trader. she understands what hedgie has been up to since 2008. Ballas was a fool in 2018...but he's got some smarter heads on line.
I think once James A. Ballas is the ONLY person who can sell A/S, you'll see selling. but under smart advisement, and selling only so that minimal remaining A/S is used, and UBQU (and GDET) can get out of debt.
once cash flow positive, then I'll be focusing on the fundamentals of the company.
hehe, way back in 2018 a certain person who tempted me with smoke and mirrors told me James A. Ballas came on this very forum. further claims are that Ballas has folks read this forum.
indeed I don't want to claim its my posting which educated him. so many youtubes, millions upon millions of folks who now know hedge funds games and how to disrupt the short selling supply.
but that's why I post. Maybe James A. Ballas got the idea from these posts. dunno doncare, but it's clear to me he understands now. that's why I'm sure of no R/S, and any massive dumping of Billions under 10 will be another toxic converter.
well folks it's clear I worry some folks with a short position on this forum. so you might need to, if you want to know more, contact me in PM.
and I'm not reiterating anything I haven't since october. but I want to post my thesis again and be considered on topic.
thank you for your time.
Recent UBQU News
- Ubiquitech Software Corporation Retains Vitello Capital Ltd. to Aid Strategic Planning and Assess Global Acquisition Opportunities • InvestorsHub NewsWire • 10/11/2023 12:09:01 PM
- Ubiquitech Reports Convertible Debt Forgiveness in Excess of $1,000,000 • InvestorsHub NewsWire • 06/22/2023 12:44:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM